Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tert-Butyl Formate SCHEMBL27673285 | 0.90 | TDP1 (0.43) | TDP1 | |
| Tert-Butyl Formate SCHEMBL27673276 | 0.89 | TDP1 (0.50) | TDP1 | |
| Tert-Butyl Formate SCHEMBL28092409 | 0.83 | TDP1 (0.56) | TDP1 | |
| Tert-Butyl Formate SCHEMBL17956832 | 0.80 | TDP1 (0.48) | TDP1 | |
| Tert-Butyl Formate SCHEMBL28328144 | 0.78 | TDP1 (0.50) | TDP1 | |
| Tert-Butyl Formate SCHEMBL27758864 | 0.76 | TDP1 (0.43) | TDP1 | |
| Tert-Butyl Formate SCHEMBL17956858 | 0.76 | TDP1 (0.52) | TDP1 | |
| 1,2,3,4-Tetrahydroisoquinoline SCHEMBL16291277 | 0.75 | PNMT (0.61) | TDP1 | |
| Tert-Butyl Formate SCHEMBL17956883 | 0.74 | TDP1 (0.68) | TDP1 | |
| Tert-Butyl Formate SCHEMBL28092916 | 0.74 | TDP1 (0.68) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105705501-B | ROR gamma modulators | 百时美施贵宝公司 | 2019-04-19 | — | — | CN | disclosed |
| CN-105705501-A | Ror[Gamma] modulators | 百时美施贵宝公司 | 2016-06-22 | — | — | CN | disclosed |
| CN-104918939-A | Purine inhibitors of human phosphatidylinositol 3-kinase | MERCK SHARP & DOHME | 2015-09-16 | — | — | CN | disclosed |
| CN-1886392-A | Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder | BIOVITRUM AKTIEBOLAG (SE) | 2006-12-27 | — | — | CN | disclosed |